title: Nitric oxide in rostral ventrolateral medulla regulates cardiac-sympathetic reflexes: role of synthase isoforms.
abstract: Our previous studies have shown that nitric oxide (NO) synthase (NOS)-containing neurons in the rostral ventrolateral medulla (rVLM) are activated during cardiac sympathoexcitatory reflexes (Refs. 12 and 13). However, the precise function of NO in the rVLM in regulation of these reflexes has not been defined. Three isoforms of NOS, including neuronal NOS (nNOS), inducible NOS (iNOS), and endothelial NOS (eNOS), are located in the rVLM. We explored the role of NO, derived from different NOS isoforms in the rVLM, in processing cardiac-sympathetic reflexes using whole animal reflex and electrophysiological approaches. We found that, in anesthetized cats, increased mean arterial blood pressure and renal sympathetic nerve activity elicited by epicardial application of bradykinin (BK; 1-10 microg/ml, 50 microl) were significantly attenuated following unilateral rVLM microinjection of the nonselective NOS inhibitor, N(omega)-nitro-L-arginine methyl ester (50 nmol/50 nl), or a specific nNOS inhibitor, 7-nitroindazole (7-NI; 5-10 pmol/50 nl; both P < 0.05). In contrast, the responses of mean arterial blood pressure and renal sympathetic nerve activity to cardiac BK stimulation were unchanged by unilateral rVLM microinjection of N(omega)-nitro-D-arginine methyl ester (inactive isomer of N(omega)-nitro-L-arginine methyl ester, 50 nmol/50 nl), 3-6% methanol (7-NI vehicle), N(6)-(1-iminoethyl)-L-lysine (250 pmol/50 nl; iNOS inhibitor), or N(5)-(1-iminoethyl)-L-ornithine (250 nmol/50 nl; eNOS inhibitor). Furthermore, in separate cats, we noted that iontophoresis of 7-NI (0.1 mM) reduced the increased discharge of cardiovascular sympathoexcitatory rVLM neurons in response to cardiac stimulation with BK (P < 0.05). These neurons were characterized by their responses to inputs from baroreceptors, and their cardiac rhythmicity was determined through frequency and time domain analyses, correlating their discharge to arterial blood pressure and cardiac sympathetic efferent nerve activity. These data suggest that NO, specifically nNOS, mediates sympathetic cardiac-cardiovascular responses through its action in the rVLM.
authors.affiliation: Department of Medicine, School of Medicine, University of California, Susan-Samueli Center for Integrative Medicine, Irvine, Irvine, California 92697-4075, USA. zguo@uci.edu
authors.forename: Zhi-Ling
authors.initials: ZL
authors.lastname: Guo
authors.forename: Stephanie C
authors.initials: SC
authors.lastname: Tjen-A-Looi
authors.forename: Liang-Wu
authors.initials: LW
authors.lastname: Fu
authors.forename: John C
authors.initials: JC
authors.lastname: Longhurst
mesh_terms: D000200:Action Potentials; D000818:Animals; D017704:Baroreflex / Q000187:drug effects; D001794:Blood Pressure; D001920:Bradykinin / Q000378:metabolism; D002415:Cats; D004791:Enzyme Inhibitors / Q000008:administration & dosage; D005260:Female; D006321:Heart / Q000294:innervation*; D007276:Injections, Intraventricular; D007478:Iontophoresis; D007527:Isoenzymes; D007668:Kidney / Q000294:innervation; D008297:Male; D008526:Medulla Oblongata / Q000166:cytology / Q000187:drug effects / Q000201:enzymology*; D026602:Nitrergic Neurons / Q000187:drug effects / Q000201:enzymology*; D009569:Nitric Oxide / Q000378:metabolism*; D052248:Nitric Oxide Synthase Type I / Q000037:antagonists & inhibitors / Q000378:metabolism*; D052247:Nitric Oxide Synthase Type II / Q000378:metabolism; D052250:Nitric Oxide Synthase Type III / Q000378:metabolism; D010496:Pericardium / Q000378:metabolism; D010507:Periodicity; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000201:enzymology*
chemical_list: D004791:Enzyme Inhibitors; D007527:Isoenzymes; D009569:Nitric Oxide; D052248:Nitric Oxide Synthase Type I; D052247:Nitric Oxide Synthase Type II; D052250:Nitric Oxide Synthase Type III; D001920:Bradykinin
references.citation: Neurosci Lett. 2001 Sep 14;310(2-3):121-4
references.pmid: 11585582
references.citation: Am J Physiol Heart Circ Physiol. 2000 Nov;279(5):H2549-57
references.pmid: 11045993
references.citation: Br J Pharmacol. 2000 Mar;129(5):859-64
references.pmid: 10696082
references.citation: Am J Physiol Heart Circ Physiol. 2007 Dec;293(6):H3627-35
references.pmid: 17890425
references.citation: Am J Physiol Heart Circ Physiol. 2001 Nov;281(5):H2010-7
references.pmid: 11668062
references.citation: J Neurophysiol. 1985 Dec;54(6):1498-512
references.pmid: 4087045
references.citation: Auton Neurosci. 2003 Jul 31;106(2):119-31
references.pmid: 12878081
references.citation: Brain Res. 1993 Feb 19;603(2):328-32
references.pmid: 7681720
references.citation: Circulation. 2001 Oct 2;104(14):1676-81
references.pmid: 11581148
references.citation: J Neurophysiol. 1997 Jan;77(1):65-75
references.pmid: 9120597
references.citation: Mol Pharmacol. 2003 Aug;64(2):521-32
references.pmid: 12869658
references.citation: Adv Pharmacol. 1995;34:171-86
references.pmid: 8562433
references.citation: Am J Physiol. 1995 Apr;268(4 Pt 2):R958-62
references.pmid: 7733407
references.citation: Hypertension. 1997 Sep;30(3 Pt 2):704-7
references.pmid: 9323009
references.citation: Br J Pharmacol. 2003 Feb;138(4):584-93
references.pmid: 12598412
references.citation: Circulation. 1983 Apr;67(4):796-801
references.pmid: 6825235
references.citation: Am J Physiol. 1990 Sep;259(3 Pt 2):R549-60
references.pmid: 2118732
references.citation: Clin Exp Pharmacol Physiol. 2001 Mar;28(3):155-63
references.pmid: 11207669
references.citation: Neuroscience. 2003;116(1):167-78
references.pmid: 12535950
references.citation: Prog Brain Res. 1989;81:105-16
references.pmid: 2616776
references.citation: Br J Pharmacol. 2001 Jun;133(4):606-14
references.pmid: 11399678
references.citation: Am J Physiol. 1986 May;250(5 Pt 2):R815-22
references.pmid: 3706568
references.citation: Hypertension. 1996 Jan;27(1):36-42
references.pmid: 8591885
references.citation: Brain Res. 1997 Aug 1;764(1-2):265-8
references.pmid: 9295222
references.citation: Am J Hypertens. 2000 Oct;13(10):1125-34
references.pmid: 11041168
references.citation: Am J Physiol Heart Circ Physiol. 2007 Apr;292(4):H1868-75
references.pmid: 17158649
references.citation: Am J Physiol Heart Circ Physiol. 2008 Dec;295(6):H2530-40
references.pmid: 18952714
references.citation: Brain Res. 2002 Jan 18;925(1):55-66
references.pmid: 11755900
references.citation: Hypertension. 2001 Oct;38(4):896-901
references.pmid: 11641305
references.citation: Am J Physiol. 1995 May;268(5 Pt 2):H2114-24
references.pmid: 7771562
references.citation: J Physiol. 1998 Jul 15;510 ( Pt 2):633-41
references.pmid: 9706010
references.citation: J Biomed Sci. 2003 May-Jun;10(3):285-91
references.pmid: 12711855
references.citation: J Hypertens. 1996 Nov;14(11):1317-24
references.pmid: 8934360
references.citation: Brain Res. 1997 May 16;757(1):155-8
references.pmid: 9200511
references.citation: Neuroreport. 2006 Feb 27;17(3):255-9
references.pmid: 16462593
references.citation: J Physiol. 2001 Mar 1;531(Pt 2):445-58
references.pmid: 11230517
references.citation: Br J Pharmacol. 1990 Nov;101(3):746-52
references.pmid: 1706208
references.citation: Am J Physiol. 1997 Jun;272(6 Pt 2):H2843-51
references.pmid: 9227564